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INTRODUCTION 
 
 
Prematurity is the condition where the fetus enters the extrauterine 
life with biological immaturity. Maturation is defined as the process of 
completing full development or growth
[1]
. The embryo and fetus matures 
intrauterine until organ systems supports the extrauterine life.  Thus the 
degree of maturity is the foremost and main determinant for morbidity 
and mortality of the neonate. Born too soon babies are more prone for 
neurological disability, learning disabilities, injury to organs, death, 
chances of chronic illness and lifetime disability than the term newborns. 
Since there is no good direct measure for degree of maturity, gestational 
age calculated during pregnancy is used as a proxy measure of it
[1]
. 
SIGNIFICANCE OF FOCUSSING  ON PRETERM BIRTH  
        Preterm birth is a main cause of important long term loss of human 
potential among survivors world wide. Complication of prematurity is the 
single major direct cause of neonatal negative sequel. Prematurity is the 
second mostcommon aetiology of under-5 mortality, the first being 
pneumonia. Being born too soon also increases the baby's risk of 
mortality due to other reasons, mainly from neonatal sepsis. Prematurity 
is found to be a risk factor in at least half of all neonatal deaths. 
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Published in Liu L, et al., 2012 
Compared with children born at term, children who are born 
prematurely have higher  rates of cerebral palsy, sensory deficits, learning 
disabilities and respiratory illness  ( Petrou, 2005 ). 
The most obvious health impact in both developed and developing 
countries is that PTB is one of the leading causes of neonatal mortality. 
Globally it is estimated  that 11.1% of births are preterm and being born 
preterm is the direct cause of 27% of the neonatal deaths. Data from the 
United States in 2002 shows similar findings with PTB responsible for 
34% of all infant deaths. The likely difference in these figures is the 
lower rates of mortality due to various types of  infections in the United 
States.  Preterm Neonates have their organ systems poorly developed. So 
they are at risk for many life-threatening conditions like hypothermia 
because they cannot produce and retain enough heat to maintain their 
 10 
body temperatures, respiratory distress syndrome (RDS) from deficiency 
in surfactant production and lung development, bronchopulmonary 
dysplasia (BPD), cardiovascular abnormalities including patent ductus 
arteriosus (PDA) and low blood pressure, intraventricular hemorrhage 
(IVH),ineffective glucose regulation, necrotizing  enterocolitis (NEC), 
infection and retinopathy of prematurity (ROP) greater the prematurity, 
greater is the risk of morbidity and death. Even borderline preterm infants 
have a risk for poor feeding and hyperbilirubinemia. Exponential  
relationship exists between mortality and immaturity. Births that occur 
before 34 weeks of gestation though contribute to about 3 -4 % of all 
preterm birth, they account  for the majority of neonatal deaths. 
Survival of the first crucial months of life after PTB does not  mean 
that they are free from lasting adverse health effects. Disability is the 
biggest and the most obvious long-term health effect. It can be 
characterized into three major domains; mental (neuro-developmental 
impairment, NDI), physical (neuro-motor development) and sensory 
(vision, hearing). There are indices and testing time periods, thus 
comparison of studies is difficult. However, they are all uniform in 
indicating the severity of the problem. To illustrate, one cohort of 
neonates born at <26 weeks GA in England found that 30% of the 283 
tested infants had scores 2 standard deviations below the population mean 
at 30 months post expected delivery date using Bayley Mental and 
Psychomotor Development Indexes. In addition almost half (49%) were 
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classified as disabled and almost a quarter (24%) as severely disabled. 
When these same children were followed up at 6 years of age, 86%of 
those originally classified as disabled still had moderate to severe 
disability. Of the remaining cohort 46% had either moderate or severe 
disability compared to their classmates with only 20% classified as no 
disability. When these same children were followed up at 11 years of age 
46% were still seriously functionally disabled  compared to their peers. 
These data all come from the EPI Cure Study and indicate that PTB puts 
children at serious risk of disability throughout their formative years. 
There has been no solid evidence that disability outcomes are improving. 
This means that a  steadily higher proportion of children will have 
disability needs in the future. 
While the above studies focus on very preterm GAs, those born at  
later GA are not exempted from the risk. A study in the Netherlands 
comparing 8 year old school children showed that those born late preterm 
(32-36 weeks, with no  intensive care needed) were more than twice as 
likely as their term peers to need special education and to be held back in 
school. In addition the preterm group had slightly lower  IQ scores and 
more difficulty with sustained attention tasks. These studies indicate that 
even seemingly mildly truncated pregnancies have significant impact on 
future life for infants. Cognitive and neuro-motor functioning are not the 
only organ systems that are affected by being born preterm. Preterm 
neonates face many other challenges that can extend lifelong. Lung 
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development is often compromised into late childhood (11 years) with 
those born <26 weeks having high rates of chest deformities (17%) and 
asthma diagnoses (25%). These rates were significantly higher than their 
classmates and those born early also had worse spirometry scores in all 
tested areas.  
Asthma rates may be more similar to peers as these children age 
because their asthma rates in their classmates increase but those born 
preterm still have higher rates of chronic conditions. Overall growth in 
childhood can also be affected by early PTB.  
In the EPI Cure study discussed above children born <26 weeks 
GA were more likely  to have lower weight, shorter height, lower BMI 
and smaller head circumference at 6 years of age. However, these 
children had slightly caught-up with previous measurements at 30 months 
of age. 
Underlying these differences in growth are the metabolic 
implications of  being born preterm. When comparing those born preterm 
to those born at term, preterm individuals tend to have lower insulin 
sensitivity and higher blood pressures, even into their 20s. Associations 
between being born preterm and subsequent diabetes and cardiovascular 
disease have also been identified. These findings seemed to be related to 
catch-up growth, which means that correcting slow growth may not be 
without consequences. 
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Of all the health outcomes affected by being born preterm , he most 
striking example of the risk comes from a recent study on long term 
mortality risk for these infants. Following a cohort in Sweden of births 
occurring between 1973-1979, the authors found that not only were 
patients born preterm more likely to die in early childhood (age 1-5 years) 
but that this risk is resurfaced at 18-36 years of age. Deaths in early 
adulthood were most often from respiratory, endocrine and 
cardiovascular disorders. This was independent of fetal growth and 
maternal risk factors with the adjusted hazard ratio of 0.96 for each 
additional increased week of gestation. Even late preterm infants were at 
risk with those born 34-36 weeks GA having a hazard ratio of 1.31 
compared to those born at term (37-42 weeks). This suggests the potential 
importance of any extension in GA at birth that can be achieved through 
preventative measures. 
These health effects can extend to the next generation. Individuals 
born preterm are less likely to reproduce and of the women that do, they 
are more likely to have preterm infants who are at a greater risk of dying 
during infancy. This fact is especially poignant when considering the 
current racial disparities in birth outcomes.   
The rate of preterm birth is much different for minority populations 
in the US. In 2007 the rates of PTB for black infants was 18.3, for 
Hispanic 12.3 and for white 11.5. This is accompanied by a higher 
mortality rate for preterm infants in minority populations. 
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AIM OF THE STUDY 
To find out the association of urogenital infection as a risk factor 
for spontaneous preterm delivery 
DEFINITION OF PRETERM LABOUR  
Preterm labour may be defined as onset of regular uterine 
contractions associated with cervical changes i.e. cervical effacement and 
dilatation  between the period of fetal viability and before 37 completed 
weeks of gestation (WHO, 2003; ACOG , 2012). 
INCIDENCE 
Incidence of preterm birth was 12% of all deliveries and accounts 
for majority  of neonatal deaths and nearly half of all cases of congenital 
neurological disability, including cerebral palsy (Ross and Eden , 2009). 
Of all preterm births that occur, 40 - 45% result from onset of 
labour,  25-30%  result from PPROM and 30 - 35% are medical decisions 
to terminate pregnancy.  
PTBs resulting from labour or PPROM are referred to as 
spontaneous PTB.
[2]
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SUB CATEGORIES OF PRETERM 
There are two sub-categories of preterm  
Based on gestational age: 
 
PTBs  are divided into different categories . These categories are  
1. Late preterm (34-36 weeks),  
2. Moderate preterm (32-33 wks),  
3. Very preterm (28-31 wks) and 
4. Extreme preterm (< 28 wks)  (Draper et al., 1999) 
The period of viability varies in different countries. It varies from 
20 weeks to 28 weeks. In India the period of viability is 28 weeks. Hence 
its categorised  as  
* Late preterm (34-36 weeks)  
* Moderate preterm (32-33 wks) 
* Very preterm (28-31 wks)  
 16 
Based on causes and risk factors  
(1) Spontaneous preterm delivery which means spontaneous onset of 
labour. It also denotes onset of labour following preterm prelabour 
rupture of membranes (PPROM) 
(2) Provider-initiated  premature delivery which means planning for 
induction of labour or  planning  elective lower segment caesarean 
delivery before 37 completed weeks of gestation for maternal or 
fetal  indications. It may be emergency or elective for either as a 
life saving for mother or fetus, or for any other non-medical 
reasons. 
RISK FACTORS 
Type: Risk Factors: Examples: 
 
Spontaneous 
preterm birth: 
Age at pregnancy 
and pregnancy 
spacing 
Adolescent pregnancy, advanced 
maternal age, or short inter-
pregnancy interval  
 
Multiple pregnancy 
 
Increased rates of twin and higher 
order pregnancies with assisted 
reproduction 
 
 
 
Infection 
 
Urinary tract infections, 
asymptomatic bactiuria, malaria, 
HIV, syphilis, chorioamnionitis, 
bacterial vaginosis 
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Type: Risk Factors: Examples: 
 
 
 
Underlying 
maternal chronic 
medical conditions 
Diabetes, hypertension, anaemia, 
asthma, thyroid disease  
 
 
Nutritional 
 
Undernutrition, micronutrient 
deficiencies 
 
 
 
Lifestyle/work 
related 
 
Smoking, excess alcohol 
consumption, recreational drug 
use, excess physical work/activity 
 
 
Maternal 
psychological 
health 
Depression, violence against 
women  
 
Genetic and other 
Genetic risk, e.g., family history 
Cervical incompetence Intra-
uterine growth restriction 
Congenital abnormality 
 
Provider-
initiated 
preterm birth: 
 
Medical induction 
or cesarean birth 
for: 
Prior classical cesarean section, 
Placenta accreta.  
 
obstetric indication 
Fetal indication 
 
Other - Not 
medically indicated 
 
There is an overlap for indicated 
provider-initiated preterm birth 
with the risk factors for 
spontaneous preterm birth 
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PATHOGENESIS 
Preterm birth is multifactorial in origin. The risk factors like 
ischemia and infection cause the stimulation of fetal hypothalamic 
pituitary axis and it plays a major role in prematurity in addition to  
interaction of all three immune, paracrine, and endocrine systems . 
Premature labour occurs as a result of three natural processes 
occurring concurrently prior to 37 weeks of gestation. These 3 natural 
processes start in a cyclical manner resulting in an increased uterine 
contraction, fetal membrane activation and cervical ripening . 
 
  
UTERINE 
CONTRACTILITY 
MEMBRANE 
ACTIVATION 
CERVICAL 
RIPENING 
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CYTOKINES INVOLVED 
Cytokine Action Effect 
IL-6,IL-8,IL-1, 
TNF-alpha 
Degradation of collagen 
fibres 
Cervical ripening 
IL-1,TNF-alpha Induce matrix 
metalloproteinases 
Membrane rupture 
IL-1,IL-2,IL-6,TNF-
alpha 
Increases PGE2 ,PGF2 
alpha 
Uterine contraction 
 
The sequence of order of these processes will differ in various  
circumstances. But in overall uterine contraction is common to be 
initiated at first which leads to preterm activation of the other two 
processes. 
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INFECTIONS 
Infections and its related inflammation are found to be the initiators 
of preterm birth. It was found to have high positive bacterial cultures 
from the placenta and the fetal membranes of a high number of patients 
with prematurity. (Salafia et al, 1991).One fourth of all premature births 
occurs in patients with bacterial invasion of the uterine tissues (Romero, 
et al., 2007). The bacteria which cause placental infection produce            
prostaglandins, which disturbs the uterine silence and causes cervical 
ripening and softening and premature labour (Bejar, 1981). Moreover 
genital infection and its inflammatory process, will cause release of 
cytokines, which in turn causes a further rise in prostaglandin levels 
(Srinivasan, et al., 2009) 
The infections that are related to premature birth are as follows 
1. Urinary tract infections 
2. Lower genital tract infections  
3. Intrauterine infections 
4. Systemic maternal infections  
5. Maternal periodontitis 
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The infection enters into the uterus and amniotic fluid through 
various means. It can enter into the amniotic cavity hematogenously, 
incidentally by diagnostic and or therapeutic procedures like 
amniocentesis or through retrograde route it can spread from the 
abdominal cavity through the fallopian tubes
[20]
. Of all infections, 
ascending infection has high risk factor for preterm labour. Urogenital 
infections are the one that are mostly related to premature labor. These 
are the bacterial infections that are seen to ascend from the lower genital 
tract.
[21]
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ASCENDING INFECTION IS CONSIDERED TO HAVE FOUR 
STAGES 
Four steps are involved in ascending infection of vagina which are 
cervicovaginal infection, choriodecidual infection, infection of amniotic 
cavity and  infection of fetus.  
 The first stage: Change in the vaginal and cervical microbial flora 
or the presence of pathologic microbes  
 Second stage:  Deciduitis.  
 Third stage : Choriovasculitis  or Amnionitis 
 Fourth stage: Once in the amniotic cavity, the bacteria may gain 
access to the fetus by different ports of entry 
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URINARY TRACT INFECTIONS 
The urinary tract infection poses a major preventable cause of 
preterm labor. It includes asymptomatic bacteriuria, acute cystitis and 
pyelonephritis. 
In pregnancy, urinary tract infections are common because: 
1. Difficulty in maintaining proper hygiene due to a distended 
pregnant abdomen 
2. Immuno compromised condition of pregnancy 
3. Hormonal and mechanical changes causing urinary stasis 
and vesicoureteral reflux 
 Stasis of urine as a result of ureteral smooth muscle relaxation by 
progesterone 
 Urinary retention as a result of the weight of the enlarging uterus  
 Loss of ureteral tone along with increased urinary tract volume 
which in turn leads to  stasis of urine and ureteric dialation of renal 
pelvis and calyces 
  It is more common on right side (86% of cases)  
The pressure is more pronounced on right (15 mm vs 5 mm). It 
begins at 10 weeks and worsens throughout pregnancy.  
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4. Glycosuria and aminoaciduria 
 There occurs an impaired renal resorption of glucose in the 
collecting duct and Loop of Henle. 
 Selective aminoaciduria {for reason unknown} which favours 
urothelial adherence  in Escherichia coli infection. 
Infective agents  
E coli: Most common cause of UTI, 80-90% 
It originates from fecal flora colonizing the periurethral area and is 
an ascending infection.  
 Other pathogens that contributes are:  
 Klebsiella pneumoniae (5%) 
 Proteus mirabilis (5%) 
 Enterobacter species (3%) 
 Staphylococcus saprophyticus  (2%) 
 Group B beta-hemolytic Streptococcus (GBS; 1%) 
 Chlamydial infections 
 Proteus species and S saprophyticus, are very aggressive causes of 
UTI either persistent or recurrent . 
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Proteus, Klebsiella, Pseudomonas and coagulase negative 
Staphylococcus alkalinize the urine and are more prone to result in renal  
stones.  
ASYMPTOMATIC BACTERIURIA 
Asymptomatic bacteriuria is defined as a condition where single 
species of  bacteria is isolated from 1 ml of urine which shows > 100,000 
colonies. Midstream sample, is used for the culture. Prevalance is 2 to 7 
percent of pregnancy. Bacteria that is most commonly isolated is E.coli. 
Untreated asymptomatic bacteriuria may develop into pyelonephritis in 
20 to 40 % of pregnant women.
[22,23,26]
 
Risk factors for asymptomatic  bacteriuria : Increasing age (1% 
increase / decade of life),  higher parity, higher sexual activity, infection 
with chlamydia in the past, lower socioeconomic status, recurrence of 
UTI in the past, diabetes mellitus, sickle cell disease , anatomical defect 
and / or physiological genitourinary tract defects. Prematurity, low birth 
weight infants, fetal mortality, increased risk for anemia, 
thrombocytopenia and transient renal disorder are all common in 
pyelonephritis. There is a reduction in the rate of subsequent 
genitourinary tract infections, perterm birth with the treatment of 
asymptomatic bacteriuria. 
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SCREENING OF BACTERIURIA  
ACOG recommends that the urine culture should be done at the 
first prenatal visit for all women and the urine culture is recommended to 
be done again at third trimester, because there is a chance for the urine of 
treated patients not to remain sterile during all trimesters of pregnancy. 
At the first visit clean midstream catch sample is done (best if 12-
16 weeks).It identifies nearly 80% of women; if these cultures of urine if 
done monthly  it would find out an additional 2% of cases but is not 
recommended routinely 
ACUTE CYSTITIS 
Acute cystitis is characterized by inflammation of the urinary 
bladder as a result of bacterial or nonbacterial causes .The signs and 
symptoms of acute cystitis include hematuria, dysuria, suprapubic 
discomfort, frequency, urgency, and nocturia. Acute cystitis is 
complicated by upper urinary tract disease (ie, pyelonephritis) in 15-50% 
of cases. 
ACUTE PYELONEPHRITIS 
Pyelonephritis is the most common urinary tract complication in 
pregnant women, occurring in approximately 2% of all pregnancies. 
Acute pyelonephritis is characterized by fever, flank pain, and tenderness 
in addition to significant bacteriuria. Other symptoms may include 
nausea, vomiting, frequency, urgency, and dysuria. Furthermore, women 
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with additional risk factors (eg immunosuppression, diabetes, sickle cell 
anemia, neurogenic bladder, recurrent or persistent UTIs before 
pregnancy) are at an increased risk for complicated UTI. 
DIAGNOSIS OF URINARY TRACT INFECTIONS 
* Urine examination  
It includes urine analysis and culture 
All pregnant patients should undergo urinalysis and culture 
(Screening) in 1
st 
prenatal visit or at 12-16weeks to identify asymptomatic 
bacteriuria, as well as those with other associated findings like glucosuria 
and proteinuria. 
* Urine sample collection advisory 
Sample advised is midstream clean catch urine. With the first hand, 
spread the labia. Wipe the uretheral meatus with the second hand 
downwards towards the rectum using a soap–moistened towel and discard 
the towelette. The initial portion of the bladder contents are voided into 
the toilet. The middle portion of the bladder contents are held in the 
sterile container, while keeping the labia spread with the first hand . If 
sample is not transported immediately then refrigerate the specimen at 
4°C  
* Culture of urine 
  It is the  standard method to evaluate UTI .  
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 It is Indicated for :  
 UTI that are recurrent 
 Pyelonephritis 
 History of recent instrumentation 
 failure to respond to initial treatment  
 If patient is admitted at hospital 
 The  cultures said to be positive if two consecutive voided 
specimens with isolation of the same bacterial strain, at a colony 
count of 100,000 colony-forming units (CFUs) per milliliter or 
higher  
OR 
A single catheterized specimen yielding a colony count of at least  
100 CFU/mL  
 Contamination  is said to occur if  
Counts lower than 100,000 CFU/mL, with 2 or more organisms 
  WBC casts is usually present in  pyelonephritis  
 Culture results give an idea of the bacterial species and antibiotic 
sensitivity 
  If the cultures show significant mixed organisms growth, then 
renal calculi should be suspected 
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 Urinalysis 
 In urinary tract infections there will be a positive result  for nitrites, 
glucose, leukocyte esterase, WBCs, RBCs, and protein 
 Blood investigations  
 Complete hemogram 
 Blood urea nitrogen (BUN) 
 Serum creatinine  
 Serum electrolytes 
 
GENITAL INFECTIONS 
 
The female vaginal flora consists of multiple organisms. The 
Lactobacillus-Gram-positive facultative anaerobic organisms most 
commonly seen in postpubertal females
[28,29]
. There are nearly 107 
different lactobacilli microorganisms per gram of vaginal secretion. More 
than 1 type of species are seen in any one individual  
- It is a clinical syndrome caused by excessive growth of bacteria 
that may normally be present in the vagina.  
- Vagina is normally colonized with gram-positive, gram-negative, 
aerobic, and anaerobic bacteria.  
- Lactobacillus is the predominant commensal found in the vagina 
- Local pH changes causes the alteration of vaginal ecosystem. 
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-  It is not an infection 
- H2O2-producing Lactobacillus strains (eg, L jensenii) are reduced 
in number, while there are multilog population which increases in a 
characteristic set of microflora including Gardnerella vaginalis, 
genital anaerobes, and mycoplasmas.  
Microbes involved 
 G.vaginalis (coccobacilli, surface pathogen),  
 Anaerobic bacteria (Bacteroids, Mobiluncus, Prevotella) & 
 Mycoplasma hominis.  
There is a synergistic relationship between the acquired organisms.  
These organisms replace lactobacilli .These organisms produce  
amines that are volatile and some of the organic acids and lactic acids 
which lead to odour and increasing vaginal pH. Trimethylamine is 
produced by Mobiluncus that gives the odour of rotting fish. Succinate is 
synthesised by Mobiluncus & Bacteroids . 
The above products reduce the chemotactic response of neutrophils 
and reduce their ability to kill the microbes. This explains the absence of 
cellular inflammatory response. 
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The most common symptoms include:  
 Vaginal discharge and itching which is usually thin and greyish 
white.  
 Vaginal odour (foul-smelling or unpleasant fishy odour)
 The vaginal discharge and odour are often more noticeable after 
sexual intercourse.  
 The amount of vaginal discharge that is considered normal varies 
from woman to woman. Therefore, any degree of vaginal discharge 
that is abnormal for a particular woman should be evaluated. 
Additional issues that might indicate the presence of a more serious 
condition include: 
 Fever  
 Pelvic pain 
 Unbalanced pH of vagina leads to the reduced acidity which in turn 
reduces the growth of good bacteria and thus resulting in the attack 
from bad bacteria. This then increases the risk of any form of 
vaginal infections.  
• Soaps which are a bit alkaline are not advised to be used in 
intimate parts) 
• Improper  hygiene (not maintaining the Vaginal pH balance) 
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• Synthetic garments for intimate parts 
• Tightly fitting dresses 
• Sexual activity which is unprotected. (semen is alkaline and affects 
the vaginal acidity) 
•  Use of perfumed soap or wash. 
Bacterial vaginosis can be diagnosed based on few criteria. The 
Amsel criteria is routinely used. Also Nugent criteria is based on a 
numerical scoring system (0–10). The score reflects the relative 
abundance of curved gram-variable rods (Mobiluncus), large gram-
positive rods (Lactobacillus) and lastly the small gram-variable rods (G. 
vaginalis / Bacteroides spp.)
Amsel’s Criteria* Hay/Ison’s Criteria Nugent Criteria 
1) Clue cells. 
2) Fishy odor after 
adding 10% 
potassium hydroxide 
(KOH) solution. 
3) Homogeneous 
discharge - thin, 
white or yellow. 
4) pH of vaginal 
fluid >4.5 
Requires three of the 
following four signs 
or symptoms 
- Grade 1(Normal): 
Mainly Lactobacillus. 
- Grade 2 (Intermediate): 
Lactobacilli present, but 
Gardnerella or 
Mobiluncus 
morphotypes also 
present. 
- Grade 3 (Bacterial 
Vaginosis): 
Predominantly 
Mobiluncus / 
Gardnerella Reduced 
amount of Lactobacilli. 
0–3 Negative 
4–6 Intermediate 
7+  Positive for BV 
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Should we treat the asymptomatic bacterial vaginosis during 
pregnancy? 
Bacterial vaginosis is associated with premature labour due to its 
association with intrauterine infection.  
It is recommended that only patients at high risk for preterm 
delivery should be treated with antibiotics and also if they are found to 
have bacterial vaginosis. These include pregnant cases with a previous 
history of a spontaneous preterm delivery.  
As per the Centers for Disease Control and Prevention (CDC), 
advice for the treatment of Bacterial Vaginosis during pregnancy are 
listed. Patients should be reevaluated after one month of treatment.  
Metronidazole 500 mg twice daily for seven days 
Metronidazole 250 mg three times daily for seven days 
Clindamycin 300 mg twice daily for seven days 
 
INTRAUTERINE INFECTIONS 
Intrauterine infections contributes to preterm labour and is a 
preventable. Cause of preterm labour. Overall it occurs in 60 percent of 
patients with preterm delivery. For intrauterine infection to cause preterm 
birth two conditions are described. The bacteria must gain entry into the 
amniotic cavity
[12]
. It will be recognized as a foreign matter. The second 
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process involves a bacteria triggering an inflammatory response which  
induces preterm labour.  
The cytokine - prostaglandin cascade is another key player in the 
pathogenesis of preterm birth due to infection
[16]
. Bacteria weakens the 
amnion and chorion due to the inflammatory response by producing the 
inflammatory mediators. This leads to preterm prelabour rupture of 
membranes (PPROM). 
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As explained in the above chart the key role of infection associated 
with preterm is the proinflammatory cytokine prostaglandin cascade. 
These inflammatory mediators are produced in response to bacteria or 
bacterial products by macrophages, decidual cells, and fetal membranes. 
The patients with intraamniotic infection produce high concentrations of 
cytokines and prostaglandins in liquor. The production of prostaglandins 
by the amnion and the decidua is induced by these cytokines. 
PERIODONTAL INFECTION 
In oral cavity the anaerobes which are gram negative causes 
periodontitis secondary to the release of endotoxins 
(lipopolysaccharides). Those endotoxins lead to increased release of 
cytokines and prostaglandins. Periodontitis caused by oral pathogens 
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enter the systemic circulation leading intrauterine infection. Thus 
periodontitis increases the risk of preterm labour .It also plays a role in 
causation of preeclampsia and fetal loss. 
MATERNAL STRESS 
Chronic stress, in a variety of forms, has also been proposed to be a 
risk factor for PTB. Several chronically stressful conditions have been 
linked to PTB and those studied most  are depression, domestic violence, 
low socioeconomic status and working conditions
[8]
. Several prospective 
cohort studies have demonstrated that women who are depressed or 
anxious have increased risks of delivery before term.  
Risk ratios for depression and anxiety are modest typically less 
than two. 
Similarly women who were emotionally, physically or sexually 
abused during pregnancy have increased risk for delivering before term as 
well. Again, the largest of the studies typically estimate the risk ratio 
around two. Evidence for working conditions affecting pregnancy 
outcome has been less consistent due to the different populations and lack 
of similarity between study conditions. Two working conditions that have 
shown some replicable association with PTB, and are consistent with the 
chronic stress etiology, are women required to stand for several hours per 
day and those working night shifts. As with the other chronic stress 
pathways the risk ratios for these factors are small, <1.5. Contrary to 
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chronic occupational stress, exercise programs have had either no or 
positive impact on GA at birth. How physical exertion affects a 
pregnancy may depend on duration and intensity in which it is 
encountered, but these variables are difficult to quantify. Though chronic 
stress is an important pathway for contributing to PTB, it is one that is 
difficult to quantify for any individual, and thus has not been used to 
predict PTB risk. 
UTERINE OVERDISTENSION 
Uterine over distension leads to onset of preterm labour . Causes of 
uterine distention includes multiple gestations, polyhydramnios, and 
macrosomia. Uterine stretch causes overexpression of gap junction 
proteins, those gap junctions are CX-43 and CX-26 (Ou et al., 1997),also 
the oxytocin receptors (Terzidoo et al., 2005). Stretch of the lower uterine 
segment increases the levels of IL-8 and collagenase production. This 
causes ripening of cervix. (Loudon et al., 2004; Maradny et al., 1996). An 
interaction between endocrine and mechanical signals leads to 
myometrial activation and contraction. 
CERVICAL AND UTERINE MALFORMATION 
Underlying abnormalities of the uterine cervix also increase the 
risk for PTB. 
These can be both congenital and iatrogenic. Women with arcuate 
uteri, canalization defects or unification defects are all at double the risk 
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for PTB as women with normal uteri. Cervical insufficiency is also a risk 
factor for PTB although whether this is an underlying cause or the result 
of other pathological processes is difficult to differentiate. Additionally, 
women who have undergone uterine procedures have nearly double the 
risk for PTB. 
MULTIPLE PREGNANCIES 
Having a multiple pregnancy puts women at significantly increased 
risk of delivering preterm. This risk is increased with an increasing 
number of fetuses.  
While preventing naturally occurring multiple pregnancies seems 
unlikely, avoiding PTB from multiple pregnancies with assisted 
reproductive therapy (ART) is definitely possible. It has been proposed 
that increased use of ART contributed to the rise in PTB rates. This 
however is changing. The rates of twins have been rising but higher order 
multiple births has been decreasing from a peak in 1998.This may be 
related to updated guidelines to reduce the number of transferred 
embryos.  
UTEROPLACENTAL THROMBOSIS AND HEMORRHAGE 
The placenta with vascular lesions contributes to 30% of preterm 
delivery and 30% of PPROM, (Arias et al., 1993). Physiological 
transformation of the spiral arteries, atherosis, fails to occur The proposed 
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mechanism is uteroplacental ischemia and the key role is due to 
thrombin
[17]
. 
Thrombin 
 Is a protease that is multifunctional 
 causes smooth muscle contraction (vascular, and myometrial 
smooth muscle).   
 activates  protease-activated receptor 1, 3, and 4 
 it causes  to conformational change and production of 
phospholipase C, activation and G protein coupling. The  uterine 
contraction is caused by sequential changes  leading to activation 
of calmodulin, MLCK, actin, and myosin 
 there is a increase in  levels of MMP-1, 3, and 9 protein expression 
in decidual cells and fetal membranes ,which breaks the 
extracellular matrix of fetal membranes leading to PPROM 
 The measurement of thrombin-antithrombin III (TAT) complexes 
is an indirect measurement of thrombin.  
MATERNAL AGE 
Age of the mother is one of the minor influencing factor for 
prematurity. Maternal age > 30 and teenage pregnancy are said to be at 
risk for preterm labour. 
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MEDICAL ILLNESS 
Maternal medical conditions are also a risk factor for indicated 
preterm birth. Examples are chronic hypertension, prepregnancy diabetes 
mellitus alters or reduces the oxygen delivery to placenta and it also 
reduces the nutrients to the developing fetus, which results in fetal growth 
restriction. Preeclampsia, gestational diabetes mellitus has the risk of 
indicated preterm birth. Preterm birth is also caused by any acute medical 
conditions of the mother. Examples include severe trauma and shock 
which are acute conditions that could lower the placental blood flow and 
leading to non reassuring fetal status or placental abruption. This can be 
managed by terminating the pregnancy leading to premature birth. The 
progressive medical illnesses could warrant indicated preterm birth to 
preserve the health and well-being of the mother. Examples are cardiac 
diseases that are functional or structural by significant, fetal red cell 
alloimmunisation or a twin-to-twin transfusion sequence,  
GENETICS 
 There is evidence to suggest that genetic risk factors play a role 
nPredisposing the women to PTB. This genetic risk appears to be 
primarily of maternal Origin
[3]
. 
Women who have had a PTB and change of  partners remain at 
increased risk (RR ~ 5) for PTB but men show no increased risk with 
subsequent offspring. Also, having a close maternal relative with a past 
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PTB significantly increased a woman’s risk of having a PTB (RR 
~1.5).The maternal genetic component is further highlighted by twin 
studies in which monozygotic twins show greater concordance between 
gestational length of their offspring than dizygotic twins. This has led to 
estimates of the heritability of PTB of 25-40%. 
While the heritability of PTB has been confirmed in numerous 
epidemiological studies finding replicable individual genetic risk factors 
has proved elusive. Many candidate gene studies have reported 
significant association with common polymorphisms, the majority of 
which are related to inflammatory processes (IL-1, IL-6, IL-8, TNF-
alpha, etc.). To date only four polymorphisms have remained significant 
after multiple studies and meta-analysis. All increase the odds of PTB by 
a factor of <2. Only one polymorphism was found to also be significant 
in neonates.                    
To date, genome-wide association studies have been unsuccessful 
and no studies have been done to prospectively determine risk of different 
genetic polymorphisms. 
Typically, genetic studies have been performed using linkage, 
resequencing or association approaches. While these have all proven 
useful in the past they each have drawbacks. Linkage is best at 
identifying loci for monogenic Mendelian disorders, with high penetrance 
but is not as successful for common diseases with multiple contributing 
risks with lower effect sizes. Both candidate gene resequencing and 
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association studies rely on predicting the correct genes to study based on 
their theoretical potential to be related to disease. While this approach 
may highlight disease related polymorphisms in known pathways, it is 
unlikely to identify novel disease-related variants. To this end an ideal 
genetic study takes a location-agnostic approach with dense coverage to 
identifying disease risk. The first attempts at such investigations are 
known as Genome Wide Association Studies (GWAS). They use up to 
one million common variants, known as single nucleotide polymorphisms 
(SNPs), spread across the genome to achieve greater ability to detect 
potential risk. Hundreds of thousands to over a million SNPs are 
generally genotyped in a typical GWAS.  
SNPs can be chosen based on their location in haplotype blocks, 
regions of the genome that tend to be inherited together, so that any 
particular SNP acts as a surrogate, or “tag” SNP, for other 
polymorphisms within the block. The non-random, tendency for regions 
of the genome to be inherited together is known as linkage 
disequilibrium. GWAS has been very successful in identifying genetic 
risks in many common, heterogeneous diseases such as diabetes mellitus 
and breast cancer and common traits such as height. GWAS depends on 
the common disease, common variant hypothesis (CD-CV) which states 
that common diseases will have disease-predisposing variants that many 
people in the population will share. Currently, GWAS is the most cost 
effective way of examining large portions of the genome for genetic risk, 
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but they still are unlikely to find rare variants (minor allele frequency < 
1%) or those of only modest impact. However, as the cost of sequencing 
technology continues to decrease, whole exome and whole genome 
sequencing may become more readily performed. The rate limiting step 
in identifying genetic predisposition then becomes achieving adequate 
sample sizes and harnessing the necessary analytical power; not the 
amount of genetic information that can be obtained. 
PREVIOUS PRETERM BIRTH 
Previous preterm birth is the strongest risk factor for repeated 
preterm delivery. It occurs recurrent at a similar gestational age, with 
around 70% delivering within 2 weeks of the gestational age of their first 
preterm delivery (Bloom, et al., 2001). Term births decrease the risk of 
PTB in subsequent pregnancies
[14]
. 
 
 
 
 
 
 
 
 
 
FIRST 
BIRTH 
SECOND 
BIRTH 
SUBSEQUENT 
PRETERM 
BIRTH 
(%) 
Not preterm  4.4 
Preterm  17.2 
Not Preterm  Not Preterm 2.6 
Preterm   Not Preterm 5.7 
Not preterm  Preterm 11.1 
Preterm  Preterm 28.4 
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OBESITY, DIABETES AND METABOLIC SYNDROME 
Many lifestyle factors influence a woman’s risk for PTB, including 
body mass index (BMI). There is a somewhat non-intuitive relationship 
between maternal BMI and PTB. First, women who are underweight are 
prone to deliver early. A recent metaanalysis found that women classified 
as underweight (typically BMI < 18.5 or 20) had a significantly increased 
risk of PTB (RR=1.21). Also, convincingly, in this metaanalysis when 
considering only the largest included studies, all showed increased risk, 
with somewhat higher risk ratios. The increased risk was true of both 
spontaneous and induced PTBs. At the other end of the BMI spectrum a 
higher BMI may be protective of PTB. In a meta-analysis examining 
higher BMI and its association to PTB, BMIs between 25-30 and 30-35 
were found to be protective for PTB with risk ratios of 0.85 and 0.83. 
However, risk for PTB between 32-36 weeks was increased in these 
groups. This apparent protective effect disappeared above a BMI of 35 as 
women with a BMI between 35-40 and >40 were at increased risk of PTB 
(RR=1.33 and 2.27). Obesity especially increased the risk for induced 
PTB. 
Metabolic disorders such as diabetes are often co-existent with 
high BMI and can have their own risk for PTB. Women with pre-existing 
diabetes mellitus have been found to be at risk for spontaneous PTB and 
especially for induced PTB. A similar condition, metabolic syndrome, 
can also produce ill effects on birth outcomes. A cohort study found that 
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women classified with metabolic syndrome in early pregnancy had nearly 
3 times the risk of delivering preterm. Again, the risk was especially 
strong for induced PTB(RR>5) 
PRETERM PRELABOUR RUPTURE OF MEMBRANES 
(PPROM) 
A woman is described as having P-PROM if she has ruptured 
membranes before 37
+0
 weeks of pregnancy but is not in established 
labour. (NICE GUIDELINES 2015) 
 Premature labour is usually preceeded by preterm prelabour 
rupture of membranes. Inspite of any etiology and mechanism leading to 
preterm labour is PPROM. It accounts for nearly 40 percent of preterm 
births (Shubert et al., 1992) and finds a place in final common pathway to 
preterm delivery
[17]
. It is also  associated with intraamniotic infection, use 
of tobacco, placental abruption, multiple pregnancy, previous history of  
PPROM, previous cervical amputation or any  surgery or  any laceration 
leading to a short cervix as detected by ultrasonogram, genetic disorders, 
nutrient  deficiency, connective tissue disorders, and deficiency of 
vitamin C. 
Mechanism 
The type 2 and 4 are the collagen, over which amnion and chorion 
abut the decidua and rest on a basement membrane. Underneath  this 
layer there is a fibrous layer that has collagen I, III, V, and VI types. The 
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major structural strength for the membranes is provided by the 
collagen
[25]
. Rupture of membranes is a process like that of a wound 
healing, in which  degradation of collagen occurs (Malak and Bell, 1994). 
Collagen is lysed by Matrix metalloprotinases (MMP). Tissue 
remodelling is also caused by it. Degradation of collagen 1,2 and 3 occurs 
with MMP 1 and MMP8. Collagen types IV and V are degraded by 
MMP-2 and MMP-9  which are gelatinases. 
The  MMPs actions are under the control of their tissue inhibitors  
(TIMPs). A balance between of its activators and tissue inhibitors is 
needed for the control of its activity. The tensile strength of the fetal 
membranes are reduced with increased ratio of MMP-9 to TIMP type 1 
.In amnion and chorion mRNA of  MMP type 1 to 3, 8, 9, and 14; and 
their levels high  in the liquor in PPROM (Menon and Fortunato, 2004). 
In PPROM  MMP-9 levels are high in the liquor and to a lesser extent in 
patients with preterm birth (Fortunato et al., 2000a). Increased levels of 
pro-MMP-9 is found overlying the cervix in term gestation.  
Many  studies shows that  infection and inflammation change in 
fetal membrane synthesis of MMP (reviewed by Menon and Fortunato 
[2004]). Few studies show when amnion and chorion are exposed to 
bacterial products there is an rise in MMP levels and a reduction in TIMP 
levels (Fortunato et al., 1999). Collagenase is synthesised by bacteria and 
it reduce the bursting load and elasticity and leading to PPROM. 
(MacGregor et al., 1987). In intrauterine infection MMP-9 levels are high  
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in the amniotic fluid (Fortunato et al., 1999). When membranes are 
exposed to lipopolysaccharide MMP-2 levels are high in membranes 
(Fortunato et al., 2000b). 
The mechanisms causing  PPROM  (due to infection) are likely 
multifactorial. Proteases secreted by bacteria degrades collagen 
(MacGregor et al., 1987). Phospholipase A2increases the levels of 
arachidonic acid, a prostaglandin precursor (Bejar et al., 1981). 
In fetal membranes PGE2 decreases collagen synthesis. MMP-1 
and MMP-3 levels  are increased by prostaglandins in fibroblasts.  MMP 
levels are increased, TIMP levels are decreased due to  proinflammatory 
cytokines, those are interleukin -1 and TNF-α in cultured amniocytes (So, 
1993). 
Immune cell signals results in reactive oxygen species leads to an 
increase  in MMP levels (Woods, 2001).  Risk factors for PPROM, are 
found to be, increase reactive oxygen species levels smoking, cocaine 
use, and intra-amniotic infection vaginal bleeding by a various  
mechanisms. MMP-9 action is increased by exposure to superoxides and 
it induces the release of arachidonic acid, a precursor to PGE2. 
Multiple pregnancy polyhydroamnios causes Stretching of the 
membranes and causes PPROM. This is said to occur due to increased 
PGE2, IL-8, and MMP-1 activities (Maradny et al., 1996). 
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PROVIDER INITIATED PRETERM LABOUR 
Iatrogenic premature birth contributes 30% of all premature 
deliveries. Iatrogenic premature birth also can occur with the elective 
delivery of a baby which was thought to be term due to errors in 
gestational age assessment. Medically-indicated preterm birth can be 
categorised into maternal and fetal  cause of which severe preeclampsia,  
abruption of placenta, rupture of uterus, fetal distress and restriction of 
fetal growth with abnormal cardiotocograph are  important direct causes  
Underlying maternal conditions like renal disorders, systemic 
hypertension, obesity and diabetes milletus increase the risk of maternal 
complications like, preeclampsia and medically warranted preterm 
delivery. Pre-eclampsia and  abruptio placenta affects approximately 7% 
and 1% of all pregnancies respectively. Along with restriction of fetal 
growth and premature rupture of the membranes, they pose the most 
common reasons for indicated preterm birth (Goldenberg, 2008, Plunket, 
2008).Multiple gestations constitutes 10% of all preterm delivery, the 
majority of which, (50%), are delivered premature due to medical 
indications (Moutquin, 2003).  It is the responsibility of the obstetrician  
to weigh up the benefits of prolonging the pregnancy against delivering 
the baby too soon considering the health and medical status of mother and 
the fetus with a balance of the fetus perinatal outcome 
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PREDICTORS OF PRETERM BIRTH  
1. Risk factor assessment 
2. Cervical ultrasonography (Cervix Length assessment) 
3. Salivary estriol 
4. Screening for infections 
5. Screening for fetal fibronectin 
RISK FACTOR ASSESSMENT 
Detailed history of patients past history, medical history, race 
ehinicity, previous labour details should be elicited 
CERVICAL LENGTH ASSESSMENT  
Ultrasound is done to identify  the length of cervix as the risk of 
preterm labor is inversely related to cervical length .Trans abdominal 
scan is not so preferred as:  {full bladder, false lengthening and can 
obliterate gross funneling}
[13]
. Transvaginal scan is preferred as it is more 
accurate than digital measurements. In asymptomatic women length of 
cervix and its risk for preterm labour is given below. 
 11-20 mm: 4% risk  
 10 mm: 15% risk  
 <10 mm high risk 
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It is not screened routinely but done for high risk asymptomatic 
women at 22 – 24 weeks 
FETAL FIBRONECTIN  
It is a Glycoprotein produced by the chorion. Normally present in 
cervical secretion in early gestation and just before term labor. Its 
presence after >24 weeks is a marker for the disruption of the 
chorioamnion and underlying decidua due to inflammation with or 
without infection [13]. 
 If test is negative  , then< 1%  will deliver in next week or two and 
 False positive occurs in cases of  bleeding, ruptured membranes 
and digital cervical examination 
 False negative occurs in use of  lubricant soap 
 Screenig of asymptomatic  women at low risk is not recommended 
 Useful in women when symptoms occurs between 24-34 weeks 
 When membranes are intact and cervical dilatation is <3 cm 
 It is used for  short term prediction ( 7-14 days)then risk of  PTD 
on next week or two is 20%.  
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SALIVARY ESTRIOL  
Maternal levels of serum estradiol and salivary estriol increases 
before onset of term and preterm labour 
A cut off >2.1 ng/dl yielded a sensitivity of 40%, specificity of 
93%. 
Its levels are influenced by diurnal pattern (lowest during day, 
highest in night), and corticosteroids suppresses estriol value. 
MANAGEMENT OF PRETERM LABOUR 
 Prevention of preterm labour if possible 
 To arrest preterm labour if not contraindicated 
 Appropriate management of labour 
 Effective neonatal care 
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PRIMARY PREVENTION 
Public Educational Interventions: 
 Greater awareness should be created of the increased risk of 
preterm delivery in higher order births in ART could affect 
attitudes and choices made in fertility care. 
 To reduce the prevalence of smoking[18]. 
 Awareness should be created for the use of condoms to prevent 
sexualy transmitted diseases. 
 Recognition and early treatment of psychological factors like 
depression stress factors and other risk factor. 
Public and professional policies:  
 Policies promulgated by fertility specialists intended to reduce the 
risk of higher order have been successful in Europe. 
 Policies to protect pregnant women include minimum paid 
pregnancy leave, time off for prenatal visits, exemption from night 
shifts and protection from work place hazards 
 Promotion of long acting reversible contraceptives 
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SECONDARY PREVENTION  
Before pregnancy : Interventions include correction of mullerian 
anomalies, Preconceptional abdominal circlage, modification of maternal 
activities  
Nutritional supplements, enhanced prenatal care and periodontal 
care 
1. Wipe front-to-back after urinating or defecating 
2. Wash hands before using the toilet 
3. Use washcloths to clean the perineum 
4. Use liquid soap to prevent colonization from bar soap 
5. Clean the urethral meatus first when bathing 
6. Changes in coital patterns (eg, position, frequency, postcoital 
antibiotics) can offset recurrence in at-risk individuals.  
7. Non pharmacological factors that may help prevent recurrent 
infection in those women troubled by UTIs in pregnancy 
include:  
* Increased fluid intake. 
* Frequent voiding and a high-volume dilute 
urine, all of which reduce the risk of 
symptomatic infection 
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* The bladder to be emptied following sexual 
intercourse. Organisms at the urethera will be 
'washed away' without being massaged up the 
urethra from the perineum. 
* Double voiding (to ensure no residual urine is 
left in the bladder following micturition) To 
avoid the risk of bowel organisms getting into 
urethera perineum should be cleaned from 'front 
to back' following defecation.  
PROGESTERONE THERAPY AND PROPHYLACTIC 
CERVICAL CIRCLAGE TO PREVENT PRETERM LABOUR 
There is a decrease in myometrial progesterone receptor in preterm 
labour compared to term labor. It has anti inflammatory response, and 
causes immunosuppression so it suppresses cytokine pathways thus 
preventing rejection of fetus in utero.17 alpha hydroxyprogesterone 
caproate given weekly I.M.to women at high risk for PTL results in lower 
rates of  PTB. 
Cervical Circlage  
RCOG study concluded that 96% of elective circlages were 
unnecessary, with no perinatal improvement .  
In a post-hoc analysis those with three or more pregnancy losses 
seemed to have improved outcome 
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NICE GUIDELINES PROPHYLACTIC VAGINAL 
PROGESTERONE AND PROPHYLACTIC CERVICAL 
CIRCLAGE (GUIDELINES PUBLISHED: 20 NOVEMBER 2015) 
Offer a choice of either prophylactic vaginal progesterone or 
prophylactic cervical cerclage to women: 
 With a history of spontaneous preterm birth or mid-trimester loss 
between 16
+0
 and 34
+0
 weeks of pregnancy.  
 In whom a transvaginal ultrasound scan has been carried out 
between 16
+0
 and 24
+0
 weeks of pregnancy that reveals a cervical 
length of less than 25 mm. Discuss the benefits and risks of 
prophylactic progesterone and cervical circlage with the woman 
and take her preferences into account. 
 Offer prophylactic vaginal progesterone to women with no history 
of spontaneous preterm birth or mid-trimester loss in whom a 
transvaginal ultrasound scan has been carried out between 16
+0
 and 
24
+0
 weeks of pregnancy that reveals a cervical length of less than 
25 mm. 
 Consider prophylactic cervical cerclage for women in whom a 
transvaginal ultrasound scan has been carried out between 16
+0
 and 
24
+0
 weeks of pregnancy that reveals a cervical length of less than 
25 mm and who have either: 
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 Had preterm prelabour rupture of membranes (PPROM) in a 
previous pregnancy. 
 A history of cervical trauma. 
Infection and preterm birth 
50% of PTB associated with ascending genital tract infection eg. 
intrauterine, lower genital tract infection, distant infection like 
periodontitis  polymicrobial ureaplasma urealyticum, Mycoplasma 
hominis, anaerobes, group B streptococci, Gardnerella vaginalis, E. coli, 
peptostreptococci, Bacteroides . 
Antibiotics should not be given routinely in PTL with intact 
membranes for prolonging pregnancy. Definitely diagnosed intra-
amniotic infection either by clinical criteria (fever, uterine tenderness, 
maternal or fetal tachycardia), give i.v. antibiotics and deliver regardless 
of gestation 
TOCOLYSIS 
It is not associated with a clear reduction in perinatal or neonatal 
mortality, or neonatal morbidity. Most authorities do not recommend use 
of tocolytics at or after 34 weeks. There is no consensus on a lower 
gestational age limit for the use of tocolytic agents as per RCOG 
Guideline Grade A recommendation 2011 
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COTRAINDICATIONS TO TOCOLYSIS 
* Gestation more than 34 weeks 
* Significant vaginal bleeding 
* Suspected fetal asphyxia 
* Intra amniotic infection 
* IUD or lethal anomaly 
* Maternal indication 
* Uncontrolled diabetes 
* Severe anaemia  
* Cardiac disease 
* Severe preeclampsia or eclampsia  
* Imminent delivery 
* Maternal hypotension systolic <90 mmhg 
Drugs used as tocolytics are 
* MgSO4 
* Beta agonist 
* Calcium channel blockers 
* Prostaglandin synthase inhibitors 
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* Nitroglycerine 
* Diazoxide  
* Oxytocin receptor antagonist 
* Ethyl alcohol. 
ANTIBIOTICS 
All patients in preterm labor are considered at high risk for 
neonatal GBS sepsis and should receive prophylactic antibiotics 
regardless of culture status.           
CDC Advises Screening All Pregnant Women for Group B Strep 
35-37weeks. 
The goal of this strategy is to prevent neonatal sepsis, and not to 
prevent preterm birth.  
In cases of subclinical chorioamnionitis, determination of CRP is 
useful. 
Value < 0.9 mg/dl- continue expectant management. 
Value between 0.9-1.6- repeat in 12-24 hrs depending on clinical 
situation. 
Value of 3-4 mg/dl-almost certainly indicative of infection. 
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WHO PRETERM BIRTH GUIDELINES (AUG 2015) 
MANAGEMENT OF WOMEN IN PRETERM LABOUR AND 
MANAGEMENT OF PRETERM NEWBORN 
Recommendation for mother:  
* Use of antenatal corticosteroids 
* Use of tocolytics  
* Use of magnesium sulfate for neuroprotection  
* Antibiotic prophylaxis 
* Plan optimal mode of birth  
Strong recommendation for dose of antenatal corticosteroid 
indicated  for women at risk of preterm labour from 24 weeks to 34 
weeks of gestation when the following conditions are met:  
* Accurately calculated gestational age 
* Where preterm delivery is found to be imminent 
* There should be no clinical evidence of maternal infection 
* Adequate neonatal care is available  
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OTHER RECOMMENDATIONS 
Conditional Recommendation 
 Tocolysis (acute and maintenance treatments) are not advised for 
the purpose of improving newborn outcomes  
 Routine mode of delivery by lower segment caesarean section is 
not advised, regardless of cephalic or breech presentation 
Strong Recommendation 
 As a neuroprotection magnesium sulfate is recommended before 32 
weeks of gestation for prevention of cerebral palsy in the infant and 
child  
 Antibiotic administration is advised for women with preterm 
prelabour rupture of membranes 
 Antibiotic administration is not recommended for women in 
preterm labour with intact amniotic membranes and no clinical 
signs of infection . 
MAGNESIUM SULFATE FOR NEUROPROTECTION (NICE 
GUIDELINES PUBLISHED: 20 NOVEMBER 2015) 
 Offer intravenous magnesium sulfate for neuroprotection of the 
baby to women between 24 and 29 weeks of pregnancy who are : 
in established preterm labour or having a planned preterm birth 
within 24 hours consider intravenous magnesium sulfate for 
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neuroprotection of the baby for women between 30 and 33 weeks 
of pregnancy who are: in established preterm labour or having a 
planned preterm birth within 24 hours. Give a 4 g intravenous 
bolus of magnesium sulfate over 15 minutes, followed by an 
intravenous infusion of 1g per hour until the birth or for 24 hours. 
For women on magnesium sulfate, monitor for clinical signs of 
magnesium toxicity at least every 4 hours by recording pulse, 
blood pressure, respiratory rate and deep tendon (for example, 
patellar) reflexes. If a woman has or develops oliguria or other 
signs of renal failure: monitor more frequently for magnesium 
toxicity think about reducing the dose of magnesium sulfate. 
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REVIEW OF LITERATURE 
1. Andrews et al., Goldenberg et al., 2000 
They  conducted a study which showed that asymptomatic upper 
genital tract infection plays a major role in the pathophysiology of  early 
spontaneous preterm births, but a minority of  near term preterm births 
showed relationship between genital tract microbial infection and 
spontaneous preterm birth. The study  also showed that the availability 
and usefulness of markers to identify women with microbial genital 
infections, and the results of recent prospective  clinical trials of antibiotic 
therapy to prevent preterm birth. 
2. Goldenberg et al 2002 
He showed that of all births of United States 11 percent were of 
preterm and the resultant neonates are responsible for the majority of 
perinatal mortality and morbidity. There is recent evidence  suggesting 
that the major part of these preterm births are caused by bacterial 
infections of the chorioamnion, with the  ascending infection of the 
vagina. The mechanism  leading to preterm labour and  membrane 
rupture involves an inflammatory response leading to increased 
production of cytokines, prostaglandins, and metalloproteases.. 
3. Romero  et al 2002 
A study was conducted by Romero et al  in which he showed  the 
role of infection in premature birth. He had discussed about the pathways 
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of ascending infection, microbiology, and the frequency of intra-amniotic 
infection in leading to premature delivery, the effect of antibiotic 
administration and the perinatal outcome in patients with preterm labour 
and intact membranes, preterm premature rupture of membranes, , Group 
B streptococcus and genital mycoplasmas of the lower genital tract, 
asymptomatic bacteriuria and bacterial vaginosis was discussed in his 
study. 
4. Baldwinea  et al 2015 
Showed that the leading cause of preterm labour is in prelabour  
Premature Rupture of Membranes (PPROM) that too due to subclinical 
infection, since a huge proportion of PPROM patients are with 
chorioamnionitis. Dysbiosis facilitates the  subclinical infections. The 
vaginal microbes in amniotic fluid was characterised  in PPROM. 
5. Veleminsky et al 2008 
He conducted a study in 152 women and he has showed that infections 
are one of the most frequent causes of preterm delivery and premature 
rupture of membranes and showed that the ecosystem of vagina 
contributes to preterm delivery. Intra – amniotic infection was found to be 
a risk factor for Premature rupture of membranes (PROM) and preterm 
premature rupture of membranes (PPROM) and also contributes to the   
perinatal morbidity and mortality of newborn. 
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6. Donate et al 2010 
He performed a study for the knowledge of vaginal microbiology. 
He studied that the  vaginal microflora of a healthy asymptomatic woman 
consists of a wide variety of anaerobic and aerobic bacteria. It was 
dominated by the facultative, microaerophilic, anaerobic genus 
Lactobacillus. The  Lactobacillus is needed  to protect women from 
genital infections and to maintain the pH balance of the vaginal flora. He 
made evident that  associate abnormalities in vaginal flora lead to preterm 
labour and the neonates born too soon were with potential neonatal 
sequelae and poor perinatal outcome.  
7. Varma et al 2006 
Varma et al had performed  a study and has showed that there is an 
association between genital tract infections, such as bacterial vaginosis 
(BV), and preterm delivery (PTD) with premature delivery but meta-
analyses have been performed to show that screening and treating 
bacterial vaginosis in pregnancy does not prevent premature delivery. So 
it caused  doubt on the cause and effect relationship between the both. 
However, the analyses gave reports of significant clinical heterogeneity, 
methodological heterogeneity and statistical heterogeneity of the included 
studies. So again he undertook a repeat meta-analysis, included published 
his trials, and applied strict criteria on data extraction. His meta-analysis  
report was that  found that screening and treating genital infections in low 
risk pregnancies produced a statistically significant reduction in 
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spontaneous preterm birth (RR 0.73; 95% CI 0.55-0.98). But this 
beneficial effect was not seen in high-risk  groups. There was a difference 
in antibiotic sensitivity between high and low risk groups and it suggested  
different causes  of the infectious process to preterm labour. This 
evidence, and with the  prior knowledge of different predisposing factors 
and prognosis between these risk groups, supports the fact that Preterm 
labour in high and low risk pregnant women are different entities and 
related to infectious cause .  
8. Petit et al 2012 
He performed a trial to show the relationship of infection with 
preterm labour.. The ascending route of infection is the foremost route 
.The ascending rout of infection showed four stages : cervical and vaginal 
infection, chorio-decidual infection, intra-amniotic infection, fetal 
infection. The intrauterine infection is usual in case of early preterm birth 
leading to an increase in neurological and pulmonary morbidity. 
Mycoplasma is commonly seen, Escherichia coli, Gardnerella vaginalis 
and streptococcus B were also isolated.  He has given few markers of the 
infection  a maternal leucocytosis greater than 15,000/mm,, a C-Reactive 
Protein greater than 20mg/l, raised fibronectin levels and/or Interleukin-6 
,  short cervix particularly before 32 weeks of gestation,  leucocytosis of 
liquor, and/or raised  interleukin levels in liquor. The major marker for 
the newborn is the CRP, but interleukin 6 can also be used for an early 
diagnosis of an infection. 
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9. Goncalves et al 2002  
In his study he had showed that the intrauterine infections are 
contributing as a cause of premature labour the microbial products induce 
inflammatory response in fetus and has elicited that it leads to the 
impending onset of preterm labor and  higher rate of perinatal morbidity. 
The most common microorganisms involved in the intra amniotic 
infections are Ureaplasma urealyticum, Fusobacterium species and 
Mycoplasma hominis.  
10. Paulo cesar giraldo et al 2012 
He and his peers in his trials showed genitourinary infections in 
pregnancy are an important cause of preterm labour so preventative 
measures must be considered during the prenatal period. In his study, the 
highest rate of vaginal infection was observed in the the preterm group 
was 53.0%.The full term group showed 49.3%; the rate of infection. 
Trichomoniasis was also associated with genital infection; however, in 
the present study, its presence was insignificant, and only one (01) case 
was identified in each group.  
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MATERIALS AND METHODS 
TYPE OF STUDY  
Case control study 
PERIOD OF STUDY 
APRIL 2016- SEPTEMBER 2016 
PLACE OF STUDY 
AN OPD, Labour ward &AN Ward 
Dept of Obstetrics & Gynaecology  
 
Govt Kilpauk Medical College &Hospital, Chennai  
 
SAMPLE SIZE  
Sample size was determined based on a case control study on 
correlation between genitourinary infection and preterm labour authored 
by Udaykumar M Patel et al, published in NJMR│Volume 5│Issue 
1│Jan – March 2015 
DESCRIPTION 
* The confidence level is estimated at 95% 
* with a z value of 1.96 
* the confidence interval or margin of error is estimated at +/-10 
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* Assuming that 40 percent of the sample will have the specified 
attribute p% =40.00 and q%=60.00 
n = p% x q% x [z/e%] ² 
n= 40 x 60 x [1.96/5]² 
n= 92.19 
ASSUMING THAT 80 PERCENT AS POWER OF THE STUDY, 
MINIMUM SAMPLE SIZE REQUIRED FOR THE STUDY WAS 
CALCULATED TO BE 92 
In our study we have taken 100 as sample size (n=50 in preterm 
group and n=50 in term group) 
METHODOLOGY 
After clearance from the hospital ethics committee, this case–
control study was undertaken in the Department of Obstetrics and 
Gynaecology at Kilpauk  Medical College and Hospital Chennai from 
April 2016 to September 2016. Written informed consent was obtained 
from the women  explaining it to them in their  language they best 
understand. Minimum sample size of women with 7 % prevalence of 
genito urinary infections among antenatal cases not having preterm labor 
and 30 % prevalence of  genito urinary infections among antenatal cases 
in preterm labor, with a confidence limit of 95 % and a power of 80 was 
 69 
calculated to be 52 in each group using SPS statistical software package 
(version 17).  
Inclusion criteria: Only women with singleton pregnancy were 
included in this study. Case group I included the antenatal patients who 
was admitted in the labor ward with threatened preterm labor and in 
preterm labor with or without rupture of membranes after 28 weeks and 
before 37 completed weeks of gestation. Control group II consisted of 
antenatal women visiting antenatal Outpatient department of the hospital 
for routine antenatal check-up at completed or more than 37 weeks of 
gestation with  or without  history of preterm labor and matched to the 
case group with respect to age(teenage pregnancy, pregnancy at 20–30 
years, and pregnancy after 30 years) and parity (primigravida or 
multigravida). 
Exclusion criteria: Women with twin pregnancy or higher-order 
pregnancy, and women with antepartum hemorrhage were excluded from 
the study. Preterm labor was documented according to ACOG criteria 
(1997) as four uterine contractions in 20 min or eight in 60 min plus 
progressive change in the cervix; cervical dilatation greater than 1 cm; 
and cervical effacement 80 % or greater at gestation 37 completed weeks. 
Threatened preterm labor was described as four uterine contractions in 20 
min or eight in 60 min plus cervical dilatation less than 1 cm; and cervical 
effacement less than 80%. Leaking, i.e., rupture of membranes was 
diagnosed by per speculum examination and confirmed by litmus paper 
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(change of colour from red to blue). All women were evaluated by 
detailed history compiled with special emphasis on previous history of 
preterm labor, previous bad obstetric history and urogenital infections. 
Gestational age was calculated from date of last menstrual period using 
Naegeles formula or by first ultrasound in the first trimester of pregnancy. 
All women underwent general physical, systemic, and obstetrical 
examinations. Samples from posterior fornix of vagina were taken with 
two sterilized swabs under direct vision using Cusco/Sims speculum 
before first vaginal examination and were studied for gram stain 
characteristics and culture-sensitivity by standard methods. Mid stream 
urine sample was sent for cytology and culture-sensitivity. Sample for 
aerobic culture sensitivity was sent immediately to the Microbiology 
Department of the hospital and taking all aseptic precautions; these 
samples were inoculated on blood agar and MacConkey’s agar using 
semi-quantitative method of inoculation. The culture plates were 
incubated at 37 degree Celcius for a duration ranging from 24 to 48 
hours. Isolates were identified by standard methods. 
Women admitted with preterm labor were put on tocolytics (where 
required), or steroids therapy (\34 weeks of gestation), and antibiotics 
(cephalosporins) were started in women with ruptured membranes. 
Reports of the urine and high vaginal swab cultures were collected and 
recorded. Antibiotic therapy was started or changed according to the 
sensitivity reports. Data collected were tabulated and analysed, 
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Groups 
Groups Definition of Subjects Number 
Cases 
Women with preterm labor i.e. Uterine 
contractions occurring at a frequency of 4 
in 20 min or 8 in 60 min with cervical 
changes effacement more than or equal to 
80% and cervical dilatation > 1 cm in 
women with intact membranes or with 
rupture of membranes                                                
 
50 
controls 
 Healthy pregnant women of gestational 
age  completed or at 37 weeks with no 
history of preterm labour and matched to 
cases  group with respect to age and parity 
 
50 
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Null Hypothesis 
Null Hypothesis : H0  
Cases group equal in effect compared to 
Control group 
Alternate Hypothesis : 
H1  
Cases group hazardous in effect 
compared to Control group  
 
DATA ANALYSIS 
Descriptive statistics was done for all data and were reported in 
terms of mean values and percentages. Suitable statistical tests of 
comparison were done. Continuous variables were analysed with the 
unpaired t test... Categorical variables were analysed with the Chi-Square 
Test and Fisher Exact Test. Statistical significance was taken as P < 0.05. 
The data was analysed using SPSS version 16 and Microsoft Excel 2007. 
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STATISTICS 
Gestational Age 
 
Gestational 
Age - Groups 
Cases Controls Cases % Control % 
≤ 28 weeks 2 0 4.00 0.00 
29-32 weeks 13 0 26.00 0.00 
33-36 weeks 35 0 70.00 0.00 
37-40 weeks 0 50 0.00 100.00 
Total 50 50 100 100 
 
2 
0 
13 
0 
35 
0 0 
50 
0
10
20
30
40
50
60
Cases Controls
Gestational Age - Groups 
≤ 28 weeks 29-32 weeks 33-36 weks 37-40 weeks
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Age  
 
Age - 
Groups 
Cases Controls Cases % Control % 
≤ 21 years 0 2 0.00 4.00 
22-24 years 8 15 16.00 30.00 
25-27 years 24 23 48.00 46.00 
28-30 years 18 10 36.00 20.00 
Total 50 50 100 100 
 
 
0 
2 
8 
15 
24 
23 
18 
10 
0
5
10
15
20
25
30
Cases Controls
Age - Groups 
≤ 21 years 22-24 years 25-27 years 28-30 years
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Age Distribution Cases Controls 
Mean 26.50 25.38 
SD 1.85 2.07 
P value 
Unpaired t Test 
0.1153 
 
  
26.50 
25.38 
1.85 2.07 
0.00
5.00
10.00
15.00
20.00
25.00
30.00
Cases Controls
Age Distribution 
Mean SD
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Socioeconomic Status 
 
Socioeconomic 
Status 
Cases Controls Cases % 
Control 
% 
Lower 7 6 14.00 12.00 
Upper Lower 10 12 20.00 24.00 
Lower Middle 15 19 30.00 38.00 
Upper Middle 18 13 36.00 26.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.6805 
7 
6 
10 
12 
15 
19 
18 
13 
0
2
4
6
8
10
12
14
16
18
20
Cases Controls
Socioeconomic Status 
Lower Upper Lower Lower Middle Upper Middle
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BMI 
 
Pregnancy BMI Cases Controls Cases % Control % 
Underweight 7 9 14.00 18.00 
Normal 31 39 62.00 78.00 
Overweight 11 2 22.00 4.00 
Obese 1 0 2.00 0.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.0297 
 
7 
9 
31 
39 
11 
2 1 0 
0
5
10
15
20
25
30
35
40
45
Cases Controls
Pregnancy BMI 
Underweight Normal Overweight Obese
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Parity  
 
Parity Cases Controls Cases % Control % 
Primi 30 27 60.00 54.00 
G2A1 2 4 4.00 8.00 
G2P1L1 10 11 20.00 22.00 
G3P2L2 8 8 16.00 16.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.8556 
30 
27 
2 
4 
10 
11 
8 8 
0
5
10
15
20
25
30
35
Cases Controls
Parity 
Primi G2A1 G2P1L1 G3P2L2
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Antenatal Booking Status 
 
Antenatal 
Booking 
Status 
Cases Controls Cases % Control % 
Booked 41 45 82.00 90.00 
Unbooked 9 5 18.00 10.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.2679 
 
41 
45 
9 
5 
0
5
10
15
20
25
30
35
40
45
50
Cases Controls
Antenatal Booking Status 
Booked Unbooked
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Employment Status 
 
Employment 
Status 
Cases Controls Cases % Control % 
Employed 5 8 10.00 16.00 
Unemployed 45 42 90.00 84.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.3936 
 
  
5 
8 
45 
42 
0
5
10
15
20
25
30
35
40
45
50
Cases Controls
Employment Status 
Employed Unemployed
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Previous History of Preterm Delivery 
 
Previous History 
of Preterm 
Delivery 
Cases Controls Cases % 
Control 
% 
Yes 10 3 20.00 6.00 
No 40 47 80.00 94.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.0411 
 
10 
3 
40 
47 
0
5
10
15
20
25
30
35
40
45
50
Cases Controls
Previous History of Preterm Delivery 
Yes No
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PREVIOUS HISTORY OF PRETERM DELIVERY  
 
 
       
Single Table Analysis 
  
Disease 
   
  
(+) (-) 
  
 
(+) 10 3 13 
 
  
76.9% 23.1% 100% 
 
  
20% 6% 
  
Exposure (-) 40 47 87 
 
  
46% 54% 100% 
 
  
80% 94% 
  
  
50 50 100 
 
  
50% 50% 100% 
 
  
100% 100% 
  
 
       
Chi Square and Exact Measures of Association 
 
 
Test Value 
p-value(1-
tail) 
p-value(2-tail) 
 
 
Uncorrected chi square 4.332 0.01870 0.03739 
 
Yates corrected chi 
square 
3.183 0.03721 0.07442 
 
Mantel-Haenszel chi 
square 
4.289 0.01918 0.03836 
 
Fisher exact 
 
0.03565 0.07131 
 
Mid-P exact 
 
0.02150 0.04299 
 
 
  
All expected values (row total*column 
total/grand total) are >=5   
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Risk-Based* Estimates and 95% Confidence Intervals 
 
Point Estimates 
 
Confidence 
Limits   
 
 
 
Type Value Lower, Upper Type 
 
 
 
 
Risk in Exposed 76.92% 49.06, 92.5 Taylor series 
 
Risk in Unexposed 45.98% 35.9, 56.4 Taylor series 
 
Overall Risk 50% 40.38, 59.62 Taylor series 
 
Risk Ratio 1.673 1.15, 2.434¹ Taylor series 
 
Risk Difference 30.95% 5.764, 56.13° Taylor series 
 
Etiologic fraction in 
pop.(EFp) 
8.046% 0.1977, 15.89 
  
 
Etiologic fraction in 
exposed(EFe) 
40.23% 13.05, 58.91 
  
 
 
          
Odds-Based Estimates and Confidence Limits 
 
  
 
Point Estimates 
 
Confidence 
Limits   
 
 
 
Type Value Lower, Upper Type 
 
 
 
 
CMLE Odds Ratio* 3.866 1.04, 18.52¹ Mid-P Exact 
 
   
0.912, 23.36¹ Fisher Exact 
 
 
Odds Ratio 3.917 1.008, 15.22¹ Taylor series 
 
Etiologic fraction in 
pop.(EFp|OR) 
14.89% 1.679, 28.11 
  
 
Etiologic fraction in 
exposed(EFe|OR) 
74.47% 0.7939, 93.43 
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Urine Culture 
 
Urine 
Culture 
Cases Controls Cases % Control % 
Positive 8 2 16.00 4.00 
Negative 42 48 84.00 96.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.0437 
 
 
8 
2 
42 
48 
0
10
20
30
40
50
60
Cases Controls
Urine Culture 
Positive Negative
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x 2 Table Statistics 
Urine culture 
        
Single Table Analysis 
  
Disease 
   
  
(+) (-) 
  
 
(+) 8 2 10 
 
  
80% 20% 100% 
 
  
16% 4% 
  
Exposure (-) 42 48 90 
 
  
46.7% 53.3% 100% 
 
  
84% 96% 
  
  
50 50 100 
 
  
50% 50% 100% 
 
  
100% 100% 
  
 
       
Chi Square and Exact Measures of Association 
 
Test Value 
p-value(1-
tail) 
p-value(2-tail) 
 
 
Uncorrected chi square 4 0.02275 0.04550 
 
Yates corrected chi 
square 
2.778 0.04780 0.09560 
 
Mantel-Haenszel chi 
square 
3.96 0.02330 0.04660 
 
Fisher exact 
 
0.04582 0.09165 
 
Mid-P exact 
 
0.02683 0.05365 
 
 
  
All expected values (row total*column 
total/grand total) are >=5   
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Risk-Based* Estimates and 95% Confidence Intervals 
 
 
 
Point Estimates 
 
Confidence 
Limits   
 
 
 
Type Value Lower, Upper Type 
 
 
 
 
Risk in Exposed 80% 47.94, 95.41 Taylor series 
 
Risk in Unexposed 46.67% 36.71, 56.9 Taylor series 
 
Overall Risk 50% 40.38, 59.62 Taylor series 
 
Risk Ratio 1.714 1.172, 2.508¹ Taylor series 
 
Risk Difference 33.33% 6.486, 60.18° Taylor series 
 
Etiologic fraction in 
pop.(EFp) 
6.667% 
-0.09164, 
13.42   
 
Etiologic fraction in 
exposed(EFe) 
41.67% 14.66, 60.13 
  
 
 
          
Odds-Based Estimates and Confidence Limits 
 
  
 
Point Estimates 
 
Confidence 
Limits   
 
 
 
Type Value Lower, Upper Type 
 
 
 
 
CMLE Odds Ratio* 4.509 0.9791, 32.57¹ Mid-P Exact 
 
   
0.8356, 45.89¹ Fisher Exact 
 
 
Odds Ratio 4.571 0.9195, 22.73¹ Taylor series 
 
Etiologic fraction in 
pop.(EFp|OR) 
12.5% 0.8152, 24.18 
  
 
Etiologic fraction in 
exposed(EFe|OR) 
78.13% -8.758, 95.6 
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Organism Isolated in urine 
 
Organism 
Isolated in urine 
Cases Controls 
Cases 
% 
Control 
% 
P value 
Fishers 
Exact Test 
Escherichia coli 5 2 10.00 4.00 0.2739 
Enterococcus 1 0 2.00 0.00 0.5000 
Stapylococcus 
aureus 
2 0 4.00 0.00 0.2475 
Nil 42 48 84.00 96.00  
Total 50 50 100 100  
5 
2 1 0 
2 
0 
42 
48 
0
10
20
30
40
50
60
Cases Controls
Organism Isolated in urine 
Escherichia coli Enterococcus Stapylococcus aureus Nil
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High Vaginal Swab 
 
High 
Vaginal 
Swab 
Cases Controls Cases % Control % 
Positive 14 5 28.00 10.00 
Negative 36 45 72.00 90.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.0245 
 
14 
5 
36 
45 
0
5
10
15
20
25
30
35
40
45
50
Cases Controls
High Vaginal Swab 
Positive Negative
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Organism Isolated in HVS 
 
Organism Isolated 
in HVS 
Cases Controls 
Cases 
% 
Control 
% 
P value 
Fishers 
Exact Test 
Escherichia coli 4 3 8.00 6.00 0.7180 
Enterococcus 7 2 14.00 4.00 0.0952 
Stapylococcus 
aureus 
3 0 6.00 0.00 0.1212 
Nil 36 45 72.00 90.00  
Total 50 50 100 100  
4 3 
7 
2 3 
0 
36 
45 
0
5
10
15
20
25
30
35
40
45
50
Cases Controls
Organism Isolated in HVS 
Escherichia coli Enterococcus Stapylococcus aureus Nil
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HIGH VAGINAL SWAB 
 
 
 
       
Single Table Analysis 
  
Disease 
    
  
(+) (-) 
   
 
(+) 14 5 19 
  
  
73.7% 26.3% 100% 
  
  
28% 10% 
   
Exposure (-) 36 45 81 
  
  
44.4% 55.6% 100% 
  
  
72% 90% 
   
  
50 50 100 
  
  
50% 50% 100% 
  
  
100% 100% 
   
 
       
Chi Square and Exact Measures of Association 
 
 
Test Value p-value(1-tail) p-value (2-tail) 
 
 
Uncorrected chi 
square 
5.263 0.01089 0.02178 
 
Yates corrected chi 
square 
4.159 0.02071 0.04143 
 
Mantel-Haenszel 
chi square 
5.211 0.01123 0.02245 
 
Fisher exact 
 
0.01976 0.03952 
 
Mid-P exact 
 
0.01225 0.02450 
 
 
  
All expected values (row total*column 
total/grand total) are >=5   
OK to use chi square. 
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Risk-Based* Estimates and 95% Confidence Intervals 
 
 
 
Point Estimates 
 
Confidence 
Limits   
 
 
 
Type Value Lower, Upper Type 
 
 
 
 
Risk in Exposed 73.68% 50.86, 88.55 Taylor series 
 
Risk in Unexposed 44.44% 34.12, 55.27 Taylor series 
 
Overall Risk 50% 40.38, 59.62 Taylor series 
 
Risk Ratio 1.658 1.154, 2.382¹ Taylor series 
 
Risk Difference 29.24% 6.677, 51.8° Taylor series 
 
Etiologic fraction in 
pop.(EFp) 
11.11% 1.241, 20.98 
  
 
Etiologic fraction in 
exposed(EFe) 
39.68% 13.32, 58.03 
  
 
 
          
Odds-Based Estimates and Confidence Limits 
 
  
 
Point Estimates 
 
Confidence 
Limits   
 
 
 
Type Value Lower, Upper Type 
 
 
 
 
CMLE Odds Ratio* 3.457 1.164, 11.61¹ Mid-P Exact 
 
   
1.051, 13.45¹ Fisher Exact 
 
 
Odds Ratio 3.5 1.152, 10.63¹ Taylor series 
 
Etiologic fraction in 
pop.(EFp|OR) 
20% 4.321, 35.68 
  
 
Etiologic fraction in 
exposed(EFe|OR) 
71.43% 13.21, 90.59 
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Single Table Analysis 
  
Disease 
   
  
(+) (-) 
  
 
(+) 14 5 19 
 
  
73.7% 26.3% 100% 
 
  
28% 10% 
  
Exposure (-) 36 45 81 
 
  
44.4% 55.6% 100% 
 
  
72% 90% 
  
  
50 50 100 
 
  
50% 50% 100% 
 
  
100% 100% 
  
 
       
Chi Square and Exact Measures of Association 
 
 
Test Value 
p-value(1-
tail) 
p-value(2-tail) 
 
 
Uncorrected chi square 5.263 0.01089 0.02178 
 
Yates corrected chi 
square 
4.159 0.02071 0.04143 
 
Mantel-Haenszel chi 
square 
5.211 0.01123 0.02245 
 
Fisher exact 
 
0.01976 0.03952 
 
Mid-P exact 
 
0.01225 0.02450 
 
 
  
All expected values (row total*column 
total/grand total) are >=5   
OK to use chi square. 
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Risk-Based* Estimates and 95% Confidence Intervals 
(Not valid for Case-Control studies) 
 
 
 
 
Point Estimates 
 
Confidence 
Limits   
 
 
 
Type Value Lower, Upper Type 
 
 
 
 
Risk in Exposed 73.68% 50.86, 88.55 Taylor series 
 
Risk in Unexposed 44.44% 34.12, 55.27 Taylor series 
 
Overall Risk 50% 40.38, 59.62 Taylor series 
 
Risk Ratio 1.658 1.154, 2.382¹ Taylor series 
 
Risk Difference 29.24% 6.677, 51.8° Taylor series 
 
Etiologic fraction in 
pop.(EFp) 
11.11% 1.241, 20.98 
  
 
Etiologic fraction in 
exposed(EFe) 
39.68% 13.32, 58.03 
  
 
 
          
Odds-Based Estimates and Confidence Limits 
 
  
 
Point Estimates 
 
Confidence 
Limits   
 
 
 
Type Value Lower, Upper Type 
 
 
 
 
CMLE Odds Ratio* 3.457 1.164, 11.61¹ Mid-P Exact 
 
   
1.051, 13.45¹ Fisher Exact 
 
 
Odds Ratio 3.5 1.152, 10.63¹ Taylor series 
 
Etiologic fraction in 
pop.(EFp|OR) 
20% 4.321, 35.68 
  
 
Etiologic fraction in 
exposed(EFe|OR) 
71.43% 13.21, 90.59 
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Presence of Urogenital Infection 
 
Presence of 
Urogenital Infection 
Cases Controls Cases % 
Control 
% 
Both +ve 4 1 8.00 2.00 
Urine +ve / HVS -ve 4 1 8.00 2.00 
Urine -ve  / HVS +ve 10 4 20.00 8.00 
Both -ve 32 44 64.00 88.00 
Total 50 50 100 100 
P value 
Fishers Exact Test 
0.0425 
 
4 
1 
4 
1 
10 
4 
32 
44 
0
5
10
15
20
25
30
35
40
45
50
Cases Controls
Presence of Urogenital Infection 
Both +ve Urine +ve HVS +ve Both -ve
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RESULTS AND DISCUSSION 
In my study, of  the case group 50 women were in 21–30 years of 
age group and no woman in <21 yrs  60% (30/50) of these were 
primigravida, multiparous 36% (18/50) and women with previous one 
abortion is 4% (2/50). In control group of 50 women 48 belonged to 21 to 
30 yrs age group and 2 of 50 <21 years of age. The control group 
contained 54% ( 27/50) of prime gravida, 38% (19/50) were multigravida  
and  8% (4/50) with previous one abortion, there was no statistically 
significant difference in relation to age distribution between cases group 
(mean=26.50, SD=1.85) and control group (mean=25.38, SD=2.07) with 
a p value of <0.05 as per unpaired t test. And also no statistically 
significant difference in relation to parity status between cases group 
(majority primi – 60.00%) and control group majority primi – 54.00% 
with a p value of <0.05 as per Fishers exact test. Therefore we fail to 
reject the null hypothesis that there is no difference in age distribution 
between the study groups. Case group has 9 unbooked women compared 
with control group which was statistically insignificant (P 0.2679). There 
was no statistical difference (P 0.6805) in the socioeconomic status of the 
two groups. In the case group 33 women and in control group 32 women 
belonged to upper middle and lower middle class of socioeconomic scale. 
7 women in my study were of lower socioeconomic class. No Statistical 
significance of age,  parity, booking status and employment status was 
not noted in my study. 
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There is a statistically significant difference in relation to 
pregnancy BMI status between cases group (majority normal pregnancy 
BMI – (62.00%) and control group (majority normal  pregnancy BMI – 
78.00% ) with a p value of <0.05 as per Fishers exact test. Therefore we 
reject the null hypothesis that there is no difference in pre pregnancy BMI 
status between the study groups.  
The incidence of overweight and obese category of pre pregnancy 
BMI was significantly more in cases group compared to control group by 
a percentage difference of 20.00 percentage points (83% higher). This 
difference is significant with a p-value of 0.0297 as per Fisher’s exact 
test. My observation is similar to the results of Cnattinqius et al. 
Past history of preterm labor or abortion in previous pregnancy was 
seen in 20.1%) multigravida in Case group compared with 6.22%  in 
Control group showing a significant association with p value of 0.0411 of 
the past history of abortion or preterm labor and the women going into 
preterm labor in the present pregnancy. Pandey et al., also reported that 
past history of preterm births was a significant contributory factor for 
preterm labor. 
In a study by Chhabra and Patil, 14% of women with PTL had 
urine infection and 28% had cervical colonization. My preterm group 
showed urinary tract infection in 16% and genital tract infection in 28%, 
while 4 women had both cultures positive which is comparable to the 
observations by Chhabra and Patil. Commonest microorganism isolated 
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in urine culture was E coli. and that in high vaginal swab was 
Enterococcus fecalis. In control group, urinary tract infection was seen in 
4%, positive high vaginal swab culture in 10% and both in 2.1 % women.  
In the case group, overall urinary tract infection was detected in 
16.38% (8/50) which was 3.3 times more than that in the control group 
(5.77%, 2/50). This shows that women in preterm labor had 3.3 times 
more incidence of urinary tract infection than their counterparts with term 
pregnancy. My observations are similar to the results of Pandey et al. who 
reported urinary tract infection in 20.34 % of women in preterm labor and 
those of McPheeters et al. who reported 17.1% of urinary tract infection 
in women with preterm labor and 10.9% in women without preterm labor. 
In my study, positive high vaginal swab cultures were noted in 28.00% 
(14/50) in the Case Group and 10.38% (5/50) in Control Group. Lajos et 
al., reported the prevalence of endocervical colonization to be 14.20% in 
preterm labor or premature of membranes similar to that of this study. 
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CONCLUSION 
I conclude that, in my study, that patients with high vaginal swab 
positivity are associated with a significant increase in the incidence of 
preterm labour. In other words vaginal infection was 2.80 times more in 
women with preterm labor compared to those in control group.  And 
urinary infection is 4 times higher in women with preterm labour 
compared to those in control group, which indicates a significant 
association of urogenital infections in preterm labor. Urogenital 
infections contribute significantly to the preventable causes of preterm 
labor. We recommend that women coming for first antenatal check-up 
should be investigated for the presence of asymptomatic genitourinary 
infections. Making early diagnosis of urogenital infections and treating 
them adequately with the antimicrobials will go a long way in decreasing 
the incidence of preterm labour, preterm births and associated neonatal 
and maternal morbidities. 
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MASTER CHART 
 
 CONTROL GROUP 
S.NO NAME AGE SOCIOECONOMIC STATUSBMI PARITY G.AGE ANTENATAL BOOKING STATUSPREV H/O PTLURINE CULTURE ORGANISM ISOLATED IN URINE HIGH VAGINAL SWABORGANISM ISOLATED IN HVS
1 PREMA 22 LOWER UNDERWEIGHT PRIMI 37 BOOKED      - NEGATIVE    - NEGATIVE   -
2 KANMANI 24 UPPER MIDDLE NORMAL G2P1LI 38 BOOKED NO NEGATIVE    - NEGATIVE    -
3 GANDHIMATHY 23 UPPER MIDDLE NORMAL PRIMI 39 BOOKED    - NEGATIVE     - POSITIVE   -
4 NEELAVATHY 25 UPPER LOWER NORMAL PRIMI 39 BOOKED    - NEGATIVE    - NEGATIVE    -
5 SUMATHY 22 LOWER MIDDLE NORMAL G3P2L2 38 UNBOOKED YES NEGATIVE    - NEGATIVE    -
6 PALLAVI 21 LOWER MIDDLE NORMAL G3P2L2 38 BOOKED NO NEGATIVE    - NEGATIVE    -
7 LAKSHMI 26 LOWER MIDDLE NORMAL PRIMI 39 BOOKED    - NEGATIVE    - NEGATIVE    -
8 MARIAMMAL 27 LOWER MIDDLE OBESE G2A1 37 BOOKED    - NEGATIVE   - NEGATIVE     -
9 SANDHYA 29 LOWER OVERWEIGHT PRIMI 37 BOOKED    - NEGATIVE    - NEGATIVE    -
10 RANJITHA 25 UPPER MIDDLE NORMAL PRIMI 37 BOOKED    - POSITIVE E.COLI POSITIVE E.COLI
11 USHA 26 UPPERLOWER NORMAL PRIMI 38 UNBOOKED    - NEGATIVE    - NEGATIVE      -
12 THILAGA 27 UPPERLOWER UNDERWEIGHT PRIMI 39 UNBOOKED    - NEGATIVE    - NEGATIVE     -
13 MAHALAXMI 28 UPPERLOWER UNDERWEIGHT G2P1L1 38 BOOKED NO NEGATIVE    - NEGATIVE     -
14 VIDYA 24 UPPER MIDDLE OVERWEIGHT G2P1L1 39 BOOKED NO NEGATIVE    - NEGATIVE      -
15 RAJESWARI 25 UPPER MIDDLE OVERWEIGHT G2P1L1 37 BOOKED NO NEGATIVE    - NEGATIVE      -
16 DEVI 23 LOWER MIDDLE NORMAL G3P2L2 40 BOOKED    - NEGATIVE    - NEGATIVE    -
17 BAKIALAXMI 24 LOWER MIDDLE NORMAL G2A1 40 BOOKED    - NEGATIVE    - NEGATIVE     -
18 VIJAYA 25 LOWER MIDDLE NORMAL PRIMI 38 BOOKED    - NEGATIVE    - NEGATIVE     -
19 GIRIJA 25 LOWER MIDDLE NORMAL PRIMI 39 BOOKED    - NEGATIVE    - NEGATIVE     -
20 PAVITHRA 25 UPPER MIDDLE OVERWEIGHT PRIMI 39 BOOKED    - NEGATIVE    - NEGATIVE     -
21 THANGAM 28 UPPERM UNDERWEIGHT G2P1L1 38 BOOKED YES NEGATIVE    - NEGATIVE     -
22 GEETHA 24 LOWER UNDERWEIGHT G3P2L2 38 BOOKED NO NEGATIVE    - NEGATIVE     -
23 DEVIPRIYA 26 LOWER NORMAL PRIMI 39 BOOKED    - NEGATIVE    - NEGATIVE    -
24 NITHYA 21 UPPER LOWER NORMAL PRIMI 37 BOOKED    - NEGATIVE    - NEGATIVE     -
25 SUDARVIZHI 24 UPPER LOWER NORMAL G2A1 37 BOOKED    - NEGATIVE     - NEGATIVE    -
24 MEGALA 22 UPPER MIDDLE NORMAL G2P1L1 39 UNBOOKED NO NEGATIVE    - NEGATIVE    -
25 LATHA 29 UPPER MIDDLE NORMAL PRIMI 39 BOOKED    - NEGATIVE     - NEGATIVE    -
26 JENITHA 23 LOWER MIDDLE OBESE PRIMI 39 BOOKED    - NEGATIVE    - POSITIVE ENTEROCOCCUS
27 AISHA BANU 28 UPPERLOWER UNDERWEIGHT G2P1L1 38 BOOKED NO NEGATIVE    - NEGATIVE    -
28 PRIYANKA 28 UPPER LOWER OVERWEIGHT PRIMI 37 BOOKED    - NEGATIVE    - NEGATIVE    -
29 SOWMYA 27 UPPER LOWER UNDERWEIGHT G3P2L2 38 BOOKED NO NEGATIVE    - NEGATIVE    -
30 REVATHY 26 LOWER MIDDLE UNDERWEIGHT G2A1 38 BOOKED    - NEGATIVE    - NEGATIVE    -
31 JENNIFER 28 LOWER MIDDLE OVERWEIGHT PRIMI 39 BOOKED    - NEGATIVE    - POSITIVE ENTEROCOCCUS
32 JOTHI 26 LOWER MIDDLE NORMAL PRIMI 40 BOOKED    - NEGATIVE     - NEGATIVE    -
33 BHAVANI 23 LOWER NORMAL PRIMI 37 BOOKED    - NEGATIVE     - NEGATIVE    -
34 KAVERY 23 UPPER LOWER NORMAL G2P1L1 38 BOOKED NO NEGATIVE     - NEGATIVE    -
35 SUGUNA 24 UPPERMIDDLE NORMAL G2P1L1 37 BOOKED YES NEGATIVE    - NEGATIVE    -
36 GOMATHY 26 UPPER MIDDLE NORMAL PRIMI 39 BOOKED    - POSITIVE E.COLI NEGATIVE    -
37 KALPANA 25 UPPER MIDDLE NORMAL PRIMI 40 UNBOOKED    - NEGATIVE    - NEGATIVE    -
38 AMULU 27 UPPER LOWER OVERWEIGHT G3P2L2 39 UNBOOKED NO NEGATIVE    - NEGATIVE    -
39 ISHWARYA 28 UPPER LOWER NORMAL PRIMI 40 BOOKED    - NEGATIVE     - POSITIVE E.COLI
40 AMMU 26 LOWER MIDDLE NORMAL PRIMI 40 BOOKED    - NEGATIVE     - NEGATIVE    -
41 MARIAMMAL 26 LOWER MIDDLE UNDERWEIGHT PRIMI 39 BOOKED    - NEGATIVE    - NEGATIVE    -
42 SONIA 24 LOWER MIDDLE NORMAL G2P1L1 38 BOOKED NO NEGATIVE    - NEGATIVE     -
43 SUDARVIZHI 28 UPPERMIDDLE NORMAL PRIMI 37 BOOKED    - NEGATIVE    - NEGATIVE    -
44 RAMYA 25 LOWER MIDDLE NORMAL PRIMI 38 BOOKED    - NEGATIVE    - NEGATIVE    -
45 SHANTHHY 25 LOWER MIDDLE NORMAL G2P1L1 39 BOOKED NO NEGATIVE    - NEGATIVE    -
46 ROSY 27 LOWER MIDDLE NORMAL G3P2L2 39 BOOKED NO NEGATIVE    - NEGATIVE    -
47 GAYATHRI 29 LOWER MIDDLE NORMAL G2P1LI 39 BOOKED NO NEGATIVE    - NEGATIVE    -
48 DURGADEVI 25 UPPER MIDDLE NORMAL G3P2L2 38 BOOKED NO NEGATIVE     - NEGATIVE    -
49 ESWARI 24 UPPER MIDDLE NORMAL PRIMI 39 BOOKED    - NEGATIVE    - NEGATIVE    -
50 REGINA 29 LOWER OVERWEIGHT PRIMI 39 BOOKED   - NEGATIVE    - NEGATIVE    -
 
S.NO NAME AGE
SOCIOECONOMIC 
STATUS
BMI PARITY G. AGE
ANTENATAL BOOKING 
STATUS
WORKING 
STATUS
PREV 
H/O PTL
URINE 
CULTURE 
ORGANISM 
ISOLTED IN URINE
HIGH 
VAGINAL 
SWAB
ORGANISM ISOLATED IN 
HVS
1 ANANDHI    25 LOWER NORMAL PRIMI 35 UNBOOKED NO POSITIVE E.COLI POSITIVE E.COLI
2 ROJA 26 UPPER LOWER NORMAL G2P1L1 34 UNBOOKED NO NO POSITIVE E.COLI NEGATIVE   -
3 MADHUMITHA 24 UPPER LOWER UNDERWEIGHT PRIMI 34 BOOKED NO NEGATIVE NEGATIVE    -
4 AASYA 25 LOWER MIDDLE NORMAL PRIMI 35 BOOKED NO NEGATIVE NEGATIVE    -
5 CHRISTY 26 UPPER LOWER NORMAL PRIMI 36 BOOKED NO NEGATIVE NEGATIVE    -
6 BANU 23 UPPER MIDDLE NORMAL G2P1L1 34 BOOKED NO NO NEGATIVE POSITIVE ENTEROCOCCUS FECALIS
7 SARASWATHY 29 LOWER UNDERWEIGHT G3P2L2 32 UNBOOKED YES NO NEGATIVE NEGATIVE    -
8 INDRA 28 UPPER LOWER OBESE G2A1 34 BOOKED NO NEGATIVE NEGATIVE    -
9 LAVANYA 24 UPPER LOWER NORMAL G2P1L1 35 BOOKED NO YES NEGATIVE POSITIVE ENTEROCOCCUS FECALIS
10 RENUKA 25 LOWER MIDDLE NORMAL PRIMI 36 BOOKED NO POSITIVE ENTEROCOCCUS NEGATIVE    -
11 ALOSIUS MARY 26 LOWER MIDDLE NORMAL PRIMI 33 UNBOOKED NO NEGATIVE NEGATIVE    -
12 MUTHUMARU 29 LOWER MIDDLE NORMAL PRIMI 34 BOOKED NO NEGATIVE NEGATIVE    -   
13 SANGITHA 23 UPPER MIDDLE NORMAL G2P1L1 35 BOOKED YES NO NEGATIVE POSITIVE STAPH AUREUS
14 RANI 27 LOWER MIDDLE NORMAL PRIMI 36 BOOKED NO NEGATIVE NEGATIVE   -
15 THULASI 26 LOWER UNDERWEIGHT G3P2L2 32 UNBOOKED NO YES NEGATIVE NEGATIVE    -
16 GOMATHY 25 UPPER MIDDLE OVERWEIGHT PRIMI 31 BOOKED NO NEGATIVE NEGATIVE -
17 SIVASHANKARI 25 LOWER MIDDLE NORMAL G2P1L1 34 BOOKED NO YES NEGATIVE NEGATIVE -
18 DIVYA 26 LOWER MIDDLE OBESE PRIMI 34 BOOKED NO NEGATIVE POSITIVE E.COLI
19 KATHIJA 27 LOWE NORMAL G3P2L2 35 BOOKED NO NO POSITIVE STAPH AUREUS POSITIVE STAPH AUREUS
20 VINNARASI 27 LOWER MIDDLE OVERWEIGHT PRIMI 36 BOOKED YES NEGATIVE NEGATIVE -
21 ELAVARASI 24 UPPER MIDDLE NORMAL PRIMI 32 BOOKED NO NEGATIVE NEGATIVE -
22 SUDHA 23 UPPER MIDDLE NORMAL PRIMI 35 BOOKED NO NEGATIVE NEGATIVE -
23 SUNDARI 29 UPPER MIDDLE NORMAL G3P2L2 34 BOOKED NO YES NEGATIVE POSITIVE ENTEROCOCCUS FECALIS
24 RAJESWARI 28 LOWER UNDERWEIGHT G3P2L2 31 UNBOOKED NO YES NEGATIVE NEGATIVE -
25 SHANTHY 27 LOWER UNDERWEIGHT PRIMI 35 BOOKED NO NEGATIVE POSITIVE ENTEROCOCCUS FECALIS
26 ARTHY 29 UPPER LOWER NORMAL PRIMI 29 BOOKED NO NEGATIVE POSITIVE ENTEROCOCCUS FECALIS
27 CHITIRAISELVI 28 UPPER MIDDLE OBESE G2P1L1 30 BOOKED NO YES POSITIVE E.COLI NEGATIVE -
28 SUGANYA 28 UPPER MIDDLE NORMAL G2P1L1 28 BOOKED YES NO NEGATIVE NEGATIVE -
29 DHARANI 26 UPPER MIDDLE OVERWEIGHT PRIMI 36 BOOKED NO NEGATIVE NEGATIVE -
30 JEYAGAYATHRI 25 LOWER MIDDLE UNDERWEIGHT PRIMI 35 UNBOOKED NO NEGATIVE NEGATIVE -
31 REVATHY 25 UPPER MIDDLE UNDERWEIGHT PRIMI 34 BOOKED NO NEGATIVE POSITIVE E.COLI
CASES
32 SEETHA 25 UPPER MIDDLE NORMAL G2P1L1 28 UNBOOKED NO NO NEGATIVE NEGATIVE -
33 KRISHNAKUMARI 26 LOWER NORMAL PRIMI 32 BOOKED NO NEGATIVE NEGATIVE -
34 JEYARANI 29 UPPER MIDDLE NORMAL PRIMI 35 BOOKED NO NEGATIVE NEGATIVE -
35 RADHIKA 28 LOWER MIDDLE NORMAL PRIMI 33 BOOKED NO POSITIVE ECOLI POSITIVE ENTEROCOCCUS FECALIS
36 MALAR 27 UPPER MIDDLE OBESE PRIMI 31 BOOKED NO NEGATIVE NEGATIVE -
37 FATHIMA BEE 24 UPPER MIDDLE NORMAL G2A1 29 BOOKED NO NEGATIVE POSITIVE ENTEROCOCCUS FECALIS
38 CHELLAKILI 24 UPPER LOWER NORMAL G3P2L1 36 BOOKED NO YES NEGATIVE NEGATIVE -
39 TAMILMANI 29 UPPER MIDDLE NORMAL G3P2L2 35 BOOKED NO NO NEGATIVE NEGATIVE -
40 VANAROJA 28 UPPER MIDDLE NORMAL PRIMI 29 BOOKED YES POSITIVE STAPH AUREUS NEGATIVE -
41 DURGALAXMI 28 UPPER LOWER NORMAL PRIMI 35 BOOKED NO NEGATIVE NEGATIVE -
42 HARIPRIYA 28 UPPER MIDDLE NORMAL PRIMI 35 BOOKED NO NEGATIVE NEGATIVE -
43 ANJALAI 25 LOWER MIDDLE NORMAL PRIMI 34 BOOKED NO POSITIVE E.COLI POSITIVE E.COLI
44 DEEPA 27 LOWER MIDDLE NORMAL G2P1L1 36 BOOKED NO YES NEGATIVE NEGATIVE -
45 JEYANTHI 29 UPPER LOWER NORMAL PRIMI 33 BOOKED NO NEGATIVE NEGATIVE -
46THIRIPURASUNDARI 29 UPPER MIDDLE NORMAL PRIMI 31 BOOKED NO NEGATIVE NEGATIVE -
47 SUBATHRA 27 UPPER LOWER NORMAL G2P1L1 30 UNBOOKED NO YES NEGATIVE NEGATIVE -
48 UMAMAHESHWARI 28 LOWER MIDDLE NORMAL PRIMI 34 BOOKED NO NEGATIVE POSITIVE STAPH AUREUS
49 VALLI 29 LOWER MIDDLE NORMAL G3P2L2 35 BOOKED NO YES NEGATIVE NEGATIVE -
50 BHUVANESHWARI 27 LOWER MIDDLE OVERWEIGHT PRIMI 35 BOOKED NO NEGATIVE NEGATIVE -
  
 
 
ANNEXURE 
  
PROFORMA 
 
NAME      : 
 
AGE       : 
 
IP NO      : 
 
ADDRESS      : 
 
SOCIOECONOMIC STATUS   : 
 
OBSTETRICS HISTORY   : 
 
1. Gravida/ Parity /Gestational age 
 
2. Regular ANC 
 
3. LMP     EDD  
 
4. Living children 
 
5. Abortion 
 
6. Still birth 
 
7. Previous h/o preterm labour 
 
COMPLAINTS IF ANY   : 
 
MENSTRUAL HISTORY  : Regular /Irregular 
 
MARIETAL HISTORY   : Married since 
 
PAST HISTORY 
1. Diabetes 
2. Hypertension 
3. Heart disease 
4. Tuberculosis  
5. Epilepsy 
6. Chronic renal failure 
7. Obesity 
8. Drug intake 
 
GENERAL EXAMINATION 
FEBRILE   :    HEIGHT : 
PALLOR   :    WEIGHT : 
PEDAL EDEMA  :    BMI  : 
VITALS   : 
TEMP   :     
PULSE   : 
BP    : 
CVS    : 
RS    : 
PER ABDOMEN  :  
SPECULUM EXAMINATION : 
HIGH VAGINAL SWAB 
URINE SAMPLE COLLECTION :     
            
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
